BioBoss

James Graham: CEO of Recce Pharmaceuticals


Listen Later

James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs.

...more
View all episodesView all episodes
Download on the App Store

BioBossBy John Simboli

  • 5
  • 5
  • 5
  • 5
  • 5

5

7 ratings


More shows like BioBoss

View all
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch by Harry Stebbings

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

534 Listeners

Macro Voices by Hedge Fund Manager Erik Townsend

Macro Voices

3,072 Listeners

The a16z Show by Andreessen Horowitz

The a16z Show

1,091 Listeners

The Meb Faber Show - Better Investing by The Idea Farm

The Meb Faber Show - Better Investing

940 Listeners

Capital Allocators – Inside the Institutional Investment Industry by Ted Seides – Allocator and Asset Management Expert

Capital Allocators – Inside the Institutional Investment Industry

795 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

125 Listeners

The Readout Loud by STAT

The Readout Loud

322 Listeners

Value Hive Podcast by Brandon Beylo

Value Hive Podcast

96 Listeners

All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks & Friedberg

9,942 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

34 Listeners

Dwarkesh Podcast by Dwarkesh Patel

Dwarkesh Podcast

519 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

146 Listeners

Business Breakdowns by Colossus | Investing & Business Podcasts

Business Breakdowns

349 Listeners

In Good Company with Nicolai Tangen by Norges Bank Investment Management

In Good Company with Nicolai Tangen

182 Listeners

BG2Pod with Brad Gerstner and Bill Gurley by BG2Pod

BG2Pod with Brad Gerstner and Bill Gurley

467 Listeners